Skip to main content

Peer Review reports

From: An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial

Original Submission
13 Oct 2020 Submitted Original manuscript
14 Oct 2020 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
16 Oct 2020 Editorially accepted
26 Oct 2020 Article published 10.1186/s13063-020-04812-2

You can find further information about peer review here.

Back to article page